Literature DB >> 1550621

Management of upper extremity cumulative trauma disorders.

T R Hales, P K Bertsche.   

Abstract

1. Elements critical to a successful medical management program include cumulative trauma disorder (CTD) surveillance, conditioning and rehabilitation programs, and familiarity with OSHA recordkeeping requirements, in addition to recognition, evaluation, and treatment. 2. Occupational health care providers (HCPs) can identify high risk departments, production lines, or jobs through the passive and/or active surveillance systems. 3. The HCP should perform a CTD evaluation of employees assigned to jobs with known ergonomic hazards or areas found to have CTD problems by the surveillance system. These evaluations should consist of a medical and occupational history, and a physical examination of the upper extremities. 4. The treatment algorithm emphasizes that a) symptomatic employees need follow up to determine the effectiveness of the prescribed treatments, b) employees with severe symptoms, positive physical findings, or disorders resistant to treatment need to be referred to a physician for further evaluation, and c) conservative therapy deserves an adequate trial before surgical intervention is contemplated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550621

Source DB:  PubMed          Journal:  AAOHN J        ISSN: 0891-0162


  3 in total

Review 1.  Pathophysiological tissue changes associated with repetitive movement: a review of the evidence.

Authors:  Ann E Barr; Mary F Barbe
Journal:  Phys Ther       Date:  2002-02

2.  Exposure to repetitive tasks induces motor changes related to skill acquisition and inflammation in rats.

Authors:  David M Kietrys; Ann E Barr; Mary F Barbe
Journal:  J Mot Behav       Date:  2011-11-16       Impact factor: 1.328

3.  Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD.

Authors:  Mary F Barbe; Ann E Barr; Irene Gorzelany; Mamta Amin; John P Gaughan; Fayez F Safadi
Journal:  J Orthop Res       Date:  2003-01       Impact factor: 3.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.